Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow‐up for impact on health care‐associated infections.

MLA

Davis, Andrea, et al. “Levofloxacin Prophylaxis for Pediatric Leukemia Patients: Longitudinal Follow‐up for Impact on Health Care‐associated Infections.” Pediatric Blood & Cancer, vol. 69, no. 7, July 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1002/pbc.29525.

APA

Davis, A., Stevens, A. M., Brackett, J., Marquez, L., Foster, C. E., Sauer, H. E., & Campbell, J. R. (2022). Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow‐up for impact on health care‐associated infections. Pediatric Blood & Cancer, 69(7), 1–7. https://doi.org/10.1002/pbc.29525

Chicago

Davis, Andrea, Alexandra M. Stevens, Julienne Brackett, Lucila Marquez, Catherine E. Foster, Hannah E. Sauer, and Judith R. Campbell. 2022. “Levofloxacin Prophylaxis for Pediatric Leukemia Patients: Longitudinal Follow‐up for Impact on Health Care‐associated Infections.” Pediatric Blood & Cancer 69 (7): 1–7. doi:10.1002/pbc.29525.